Navigation Links
EVEREST Data Demonstrates Acute Reduction of Mitral Regurgitation Without Procedural Mortality in Patients Treated With the MitraClip(R) Therapy
Date:8/12/2009

MENLO PARK, Calif., Aug. 18 /PRNewswire/ -- Data published today in the Journal of the American College of Cardiology (JACC) indicates that percutaneous valve repair with the MitraClip(R) therapy can reduce acute mitral regurgitation (MR) with sustained freedom from death, surgery or recurrent MR in a substantial proportion of functional and degenerative MR patients.

The published data is from the initial cohort of 107 registry patients treated in the EVEREST (Endovascular Valve Edge-to-Edge REpair STudy) trial, sponsored by Evalve, Inc.

Seventy-four percent of patients achieved MR reduction to 2+ or less after receiving the MitraClip(R) device. In 64 percent of these, MR reduction to 1+ was achieved. Additionally, there were no cases of clip embolization or procedural mortality. Kaplan-Meier freedom from surgery was 88.5 percent, 83.2 percent and 76.3 percent at 1, 2 and 3 years, respectively. Whereas prior to the MitraClip(R) procedure 100 percent of patients were indicated for surgery.

The MitraClip(R) system is the first commercially available treatment option for non-surgical mitral valve repair for patients suffering from the effects of MR. The MitraClip(R) system is currently in late stage clinical trials in the United States and is available commercially in Europe.

MR is the most common type of heart valve insufficiency in Europe and the United States, and affects millions of people worldwide. Significant MR affects more than eight million people in the U.S. and Europe the majority of which have functional MR. There are more than 600,000 new diagnoses of significant MR each year in Europe and the U.S.; however only 20 percent of these patients undergo surgery each year. Many higher risk surgical patients and non-surgical patients continue to be affected by the chronic volume overload caused by MR, which requires the heart
'/>"/>

SOURCE Evalve, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest
2. WaterPure International, Inc. and Everest Water Ltd. Revise Payment Terms of Patent License to Produce Water From Air
3. Out of Iraq emerges hope for those with the severest of head injuries
4. Team probes why climbers die on Mount Everest
5. Most Mt. Everest Deaths Occur Near Summit During Descent
6. Study of Everest Climbers Questions Oxygen Use
7. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
8. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
9. Highmarks Hospital Pay-for-Performance Program Demonstrates Impressive Results
10. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
11. LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... the spiraling costs of drugs paid for by the ... meaningful impact on cancer chemotherapy drug costs, say a ... Oncology published online today. , "We looked at ... cancers, and did not find a substantial change in ... the recent Medicare law in 2005," says the study,s ...
(Date:9/30/2014)... Centers (FQHCs) granted new patient appointments to Medicaid ... other primary care practices (non-FQHCs), in addition to ... a new 10-state University of Pennsylvania study published ... Using data from a previous "secret shopper" study ... that FQHCs community health clinics that receive ...
(Date:9/30/2014)... 2014 Glycodrive , one of ... to help maximize lean, strong muscle growth with a ... of glucose has caught the attention of Shane Michaels, ... behind Glycodrive is to help the body use carbohydrates ... “Carbs are essential in the muscle-building process, and Glycodrive ...
(Date:9/30/2014)... 30, 2014 The American Diabetes ... help diabetics curb their sweet tooth, but the most ... this September, suggests that zero-calorie sweeteners may actually be ... , The Weizmann Institute of Science in Israel ... sweeteners to mice, the mice developed glucose intolerance. They ...
(Date:9/30/2014)... September 30, 2014 With the ... strains emerging every day, it’s a perfect time ... The EnviroShield system is an electro-static disinfectant delivery ... to surface normally missed with spray-on disinfectant applicators. ... that adds an electrostatic negative charge to the ...
Breaking Medicine News(10 mins):Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Columbus Janitorial Company Announces New Disinfecting System for your workplace 2
... Field, IRVING, Texas, Sept. 11 Over 90 ... solicitations during their training,and 80 percent received two dozen ... Merritt, Hawkins & Associates, a national physician,search firm based ... "Like blue chip athletes, new doctors are the ...
... 11 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX,: HAE), ... plasma-derived protein products for commercialization,disclosed today the ... on the use of its proprietary lead ... preventing the formation of post-surgical,adhesions in a ...
... scoop, NEW YORK, Sept. 11 If ... impact a person,s body and skin, it,s a ... procedures last,year to improve their appearances. However, New ... can improve your appearance,without going under the knife!, ...
... will be of great interest to employers and employee benefit brokers ... grounbreaking wellness and health management tool designed to help control costs ... ... (PRWEB) September 11, 2008 -- U.S. Preventive Medicine, the leader in ...
... for the medical tourism industry. Working closely with medical tourism ... trip cancellation insurance products to meet the needs of the industry. ... ... Clements International develops unique suite of insurance solutions for the medical ...
... a traumatic injury can have serious and long-lasting ... the largest-ever U.S. study evaluating the impact of ... and Research Center, the University of Washington, and ... found that post-traumatic stress disorder and depression were ...
Cached Medicine News:Health News:Survey: New Doctors Receive Dozens of Job Solicitations 2Health News:Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model 2Health News:Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model 3Health News:Insider Secrets for Beautiful Skin 2Health News:U.S. Preventive Medicine Announces Nationwide Launch of The Prevention Plan 2Health News:U.S. Preventive Medicine Announces Nationwide Launch of The Prevention Plan 3Health News:U.S. Preventive Medicine Announces Nationwide Launch of The Prevention Plan 4Health News:Clements International Develops Insurance for Medical Tourism Industry 2Health News:National study finds post-traumatic stress disorder common among injured patients 2
(Date:9/30/2014)... 30, 2014  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... advance from Hercules Technology Growth Capital, Inc. (NYSE: ... and final advance under the Loan and Security Agreement ... , Alimera Sciences Limited, entered into with Hercules ...
(Date:9/30/2014)... , Sept. 30, 2014 A study ... (OCT), offered a new look at the composition of ... how physicians understand and treat the disease, a leading ... at Baptist Health Lexington between September 2010 and May ... the Journal of the American College of Cardiology ...
(Date:9/30/2014)... Quebec , Sept. 30, 2014 Valeant ... TSX: VRX) today announced that the company,s ... Letter from the U.S. Food and Drug Administration (FDA) ... Company,s records with regards to Sculptra Aesthetic injectable, which ... Warning Letter pertains to the management of Valeant,s contract manufacturers ...
Breaking Medicine Technology:Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... Jan. 31, 2012 Halozyme Therapeutics, Inc. (NASDAQ: ... Phase 1 proof-of-concept and local tolerability study of HTI-501 ... 8th World Congress of the International Academy of Cosmetic ... commencement of the Phase 2 portion of the clinical ...
... LAKES, N.J., Jan. 31, 2012 The Board of Directors of ... declared a quarterly dividend of 45 cents per common share, payable ... 2012. The indicated annual dividend rate is $1.80 per share. ... is a leading global medical technology company that develops, manufactures and ...
Cached Medicine Technology:HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 2HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: